Page 73 - OHKF_Biotech_EN

Moreover, the Central Government can proactively explore how established in the Shenzhen park and staffed with barristers and
to best coordinate the regulatory regimes of the two cities and lawyers from Hong Kong and Macao (see Recommendation 6.2
harmonise their regulations, particularly in the area of intellectual for details); enterprises can also hire eligible barristers and lawyers
property recognition. To foster a globally competitive business trained in Hong Kong and Macao to deal with litigations in the
environment, other national organisations can consider expediting Mainland. 75
approval procedures by establishing “green channels” to facilitate
enterprises registered in the Loop to enter the Mainland market. Attracting CROs and CDMOs: It is common for conventional
We shall continue to elaborate on these proposals in Chapter 6. pharmaceutical enterprises in the biotech industry to outsource
certain procedures of the R&D process to third parties to achieve
Bridging capital, research organisations and professional cost reduction. Whereas Contract Research Organizations (CROs)
services of the two cities: In addition to integrating the can take charge of preclinical and clinical research, Contract
above-mentioned Shenzhen-Hong Kong Biotechnology Development and Manufacturing Organizations (CDMOs) can take
Collaborative Development Fund, the one-stop service platform up the Chemistry, Manufacturing and Controls (CMC) of the entire
should also link enterprises with research projects at different commercial production and R&D process, which includes quality
levels of governments in the Mainland, venture capital funds, control and production. CROs from the Mainland can establish
relevant institutions and research organisations as well as themselves in the Loop to assist Hong Kong enterprises in
professional services. On the one hand, the platform can help conducting research in the Mainland. Similarly, CROs from Hong
researchers apply for funding provided by the Central authority Kong can also establish themselves in the Loop to introduce
and various levels of local governments and collaborate with services aligned with international standards into Shenzhen,
research institutions and organisations on research; and on the including research and production services that meet regulatory
other, HK-SZ enterprises can access venture capitals of the two standards of major drug regulators of the world, as well as quality
cities via the Loop. This makes the Loop the best platform to link assurance services that meet international standards. Hong Kong
enterprises with both research and capital from both the Mainland CROs can also help with application submission to major drug
and Hong Kong. Meanwhile, enterprises can obtain legal and regulators of the world, fostering collaboration between healthcare
accounting services required in the research process via the organisations and enterprises from the Mainland and biotech
platform. In the area of intellectual property in particular, service organisations from overseas, thereby enhancing the
enterprises can obtain support on mediation and arbitration via the clinical trial capabilities and quality assurance standards of
Intellectual Property Arbitration Centre of China (Shenzhen) Mainland healthcare organisations.

75 The General Office of the State Council issued a document in October 2020 to implement a pilot measure that permits eligible legal practitioners in Hong Kong and practising lawyers in
Macao to practise in certain areas in nine cities of the Guangdong Province.
71